type full_text Clinical Summary 86 Years old femaleDA to Paracetamol NH resident PMHx 1. Dementia with Lewy body Previously dx AD with BPSD, has auditory and visual hallucinations of children and people 13/8/21: AMT 6/10 CMMSE 13/28 On Rivastigmine, Fluvoxamine and Valproate On Clonazepam 2. TIA seen in SGH [REDACTED_NUMBER]. HTN 4. HLD 5. AF with presumptive tachy induced CMP On Rivaroxaban MIBI (Oct 2019): Neg for ischemia. EF 61 on MIBI Last TTE (June 2021): EF 50 55 6. Impaired fasting glucose 7. Hep B carrier 8. Osteoporosis with L 2/ L 4 compression BMD (2017): T score left femoral neck 4.1, left hip 3.7, lumbar spine 3.0 On Alendronate 9. Unwitnessed fall cx by minimally displaced right superior pubic rami fracture, T 7,L 2 and L 4 compression fracture, long lie, bruise right frontal area, bruise right knee, scalp hematoma Conservative Mx 10. Mild OAB 11. Bilateral cataracts 12. Likely Pulmonary Malignancy family not keen for further follow up HOPC Referred in From NH for low SpO2 Noted to have spO2 of 82 85 on 5 L oxygen via face mask No fever Patient is non communicative Physical Examination BP 116/89 HR 64 RR 20 Alert Not in resp distressH S 1 S 2 L bibasal creps, AE decent b/lA SNT Not distended No tenderness Calves supple non tender Bilateral antecubital fossa macular rash notedNo rash on abdomen Progress in ED RP Cr 42 Na 132 CRP 67.6 FBC Hb 11.9 TW 9.8 IV Tazocin Issues and Progress 1. Desaturation 2' pneumonia TW 9.8 CRP 67.6 CXR (5/12/22): Mild haziness in the left retrocardiac lower zone may be related to underlying infective change. The persistent opacity in the right suprahilar region likely corresponds to the mass seen on prior CT. Started on IV tazocin which was oralised to augmentin once admitting cs NBG, to complete total 7 days Max required 2 L NP support. O2 weaned off once commenced on abx treatment Antibiotics s/p D 2 IV tazocin (5/12 7/12)PO augmentin (7/12 12/12) Patient was discharge stable on 08/12/2022. ART negative on discharge. Medication Changes Nil Care Plan Pre existing TCUs 29/3/23 CGH GER 27/4/23 Outpatient BMD 30/6/23 CGH US 14/7/23 CGH ENT